An Act relative to benzodiazepines and non-benzodiazepine hypnotics
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill addresses the use of benzodiazepines and non-benzodiazepine hypnotics, often referred to as ‘Z-drugs,’ due to concerns about their potential for misuse, addiction, and adverse health effects. The bill aims to increase awareness of these medications’ risks and promote safer prescribing practices. It also seeks to improve access to treatment for individuals struggling with dependence on these drugs. The legislation directs the Department of Public Health to conduct a study on the use and impact of these medications.
Key provisions
- Directs the Department of Public Health to conduct a study on benzodiazepine and non-benzodiazepine hypnotic use.
- Requires the Department of Public Health to develop and disseminate educational materials regarding the risks associated with these medications.
- Encourages healthcare providers to consider alternative treatments for insomnia and anxiety.
- Promotes the safe tapering and discontinuation of benzodiazepines.
Who is affected
- Patients taking benzodiazepines or non-benzodiazepine hypnotics
- Healthcare providers prescribing these medications
- The general public
- The Department of Public Health
Notable changes
- The bill mandates a state-led study to further investigate the use and impact of these medications.
- It seeks to raise awareness among both patients and healthcare professionals.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
3 on record
Primary sponsor
Cosponsors
Michael P. Kushmerek
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours